Clementia Pharmaceuticals Inc.
Related Filers (8)
- BDC CAPITAL INC. (1)
- WELLINGTON MANAGEMENT GROUP LLP (1)
- JANUS HENDERSON GROUP PLC (1)
- BAKER BROS. ADVISORS LP (1)
- ORBIMED ADVISORS LLC (1)
- Ipsen, S.A. (1)
- New Enterprise Associates 15, L.P. (1)
- The Nasdaq Stock Market LLC (1)
- Show More ...
Other (73)
15-12B
Monday, 4/29/2019
Notice of termination of registration of a class of securities under Section 12(b)
EFFECT
Thursday, 4/18/2019
Notice of Effectiveness
POS AM
Thursday, 4/18/2019
Post-effective amendment to a registration statement that is not immediately effective upon filing
25-NSE
Thursday, 4/18/2019
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
6-K
Thursday, 4/18/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/11/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/9/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Friday, 3/29/2019
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 3/13/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/6/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/28/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/26/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 2/25/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 2/25/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/20/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 2/11/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/30/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/21/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/7/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/7/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/30/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/29/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/23/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/22/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Thursday, 10/18/2018
Notice of Effectiveness
CORRESP
Tuesday, 10/16/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Friday, 10/5/2018
Registration statement for specified transactions by certain foreign private issuers
6-K
Tuesday, 10/2/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/26/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/5/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/16/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/9/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/9/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/13/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/5/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/31/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/31/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/23/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/9/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/9/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/2/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/2/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/2/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/20/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/23/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/6/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 2/28/2018
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 2/28/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/7/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/31/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/3/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/12/2017
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/5/2017
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/13/2017
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/13/2017
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/6/2017
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/31/2017
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/21/2017
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/11/2017
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CT ORDER
Friday, 8/4/2017
Order Granting Confidential Treatment
6-K
Wednesday, 8/2/2017
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
8-A12B
Tuesday, 8/1/2017
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CERTNAS
Tuesday, 8/1/2017
None
F-1MEF
Tuesday, 8/1/2017
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form F-1
EFFECT
Tuesday, 8/1/2017
Notice of Effectiveness
CORRESP
Friday, 7/28/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 7/28/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 7/24/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Friday, 7/21/2017
Registration statement for securities of certain foreign private issuers
CORRESP
Thursday, 7/13/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1
Friday, 6/30/2017
Registration statement for securities of certain foreign private issuers
CORRESP
Thursday, 6/29/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Tuesday, 7/7/2015
Exempt (Private) Offering
Ownership (15)
SC 13D
Wednesday, 3/13/2019
New Enterprise Associates 15, L.P.: Major Shareholders
SC 13D
Wednesday, 3/6/2019
Ipsen, S.A.: Major Shareholders
SC 13D/A
Friday, 3/1/2019
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G/A
Wednesday, 2/13/2019
New Enterprise Associates 15, L.P.: Major Shareholders
SC 13G
Wednesday, 2/13/2019
BAKER BROS. ADVISORS LP: Major Shareholders
SC 13G/A
Tuesday, 2/12/2019
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G
Tuesday, 2/12/2019
JANUS HENDERSON GROUP PLC: Major Shareholders
SC 13D/A
Monday, 11/5/2018
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G
Wednesday, 2/14/2018
BDC CAPITAL INC.: Major Shareholders
SC 13G
Thursday, 2/8/2018
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G
Monday, 1/29/2018
New Enterprise Associates 15, L.P.: Major Shareholders
SC 13D/A
Friday, 1/26/2018
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D/A
Friday, 1/26/2018
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D/A
Wednesday, 8/23/2017
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D
Friday, 8/11/2017
ORBIMED ADVISORS LLC: Major Shareholders
Prospectus (9)
S-8 POS
Thursday, 4/18/2019
Post-effective amendment to a S-8 registration statement
424B5
Tuesday, 10/30/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 10/29/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 10/22/2018
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Friday, 8/4/2017
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Wednesday, 8/2/2017
Prospectus filed pursuant to Rule 424(b)(4)
DRS/A
Wednesday, 6/7/2017
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 6/6/2017
Correspondence Related to Draft Registration Statement
DRS
Wednesday, 4/19/2017
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy